“The apprehension with utilizing non IID shown ingredients is justified as it truly is impossible to evaluate if FDA would find the ‘novel excipient’ safe to be used within a drug product or service as there is absolutely no described system for evaluation and approval of excipients. The FDA https://proleviate.com/